acquisition Archives -

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area,

ACELYRIN acquires ValenzaBio, strengthens immunology position

https://pharmaphorum.com/news/acelyrin-acquires-valenzabio-strengthens-immunology-position/

This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

https://pharmaphorum.com/views-and-analysis/how-to-get-acquisition-ready-a-sellers-guide-to-merger-and-acquisition-in-pharma/

The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a deal

Solid Biosciences acquires AavantiBio, conducts $75 million private placement

https://pharmaphorum.com/news/solid-biosciences-acquires-aavantibio-conducts-75-million-private-placement/

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

https://pharmaphorum.com/partner-content/welcoming-analytics-driven-digital-marketing-agency-closerlook-to-the-fishawack-health-pack/

acquisition